Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

E-cadherin expression in the epithelial components of mammary phyllodes tumors.

Tsang JY, Mendoza P, Putti TC, Karim RZ, Scolyer RA, Lee CS, Pang AL, Tse GM.

Hum Pathol. 2012 Dec;43(12):2117-23. doi: 10.1016/j.humpath.2012.03.028. Epub 2012 Jul 21.

PMID:
22820000
2.

Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.

Taira N, Takabatake D, Aogi K, Ohsumi S, Takashima S, Nishimura R, Teramoto N.

Jpn J Clin Oncol. 2007 Oct;37(10):730-6. Epub 2007 Oct 11.

PMID:
17932112
3.

Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours.

Karim RZ, Gerega SK, Yang YH, Horvath L, Spillane A, Carmalt H, Scolyer RA, Lee CS.

J Clin Pathol. 2009 Nov;62(11):1016-20. doi: 10.1136/jcp.2009.066977.

PMID:
19861560
4.

Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Tse GM, Chaiwun B, Lau KM, Scolyer R, Lee CS, Karim RZ, Putti TC, Law BK, Lui PC, Tan PH.

J Clin Pathol. 2007 Sep;60(9):1051-6. Epub 2006 Dec 8.

5.

Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.

Kuijper A, de Vos RA, Lagendijk JH, van der Wall E, van Diest PJ.

Am J Clin Pathol. 2005 May;123(5):690-8.

PMID:
15981808
6.

Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.

Feakins RM, Wells CA, Young KA, Sheaff MT.

Hum Pathol. 2000 Oct;31(10):1214-22.

PMID:
11070114
7.

p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.

Feakins RM, Mulcahy HE, Nickols CD, Wells CA.

Histopathology. 1999 Aug;35(2):162-9.

PMID:
10460662
8.

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.

Kuijper A, van der Groep P, van der Wall E, van Diest PJ.

Breast Cancer Res. 2005;7(5):R808-18. Epub 2005 Aug 5.

9.

Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.

Tsang JY, Mendoza P, Lam CC, Yu AM, Putti TC, Karim RZ, Scolyer RA, Lee CS, Tan PH, Tse GM.

Histopathology. 2012 Oct;61(4):667-74. doi: 10.1111/j.1365-2559.2012.04271.x.

PMID:
22571452
10.

Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.

Tse GM, Lui PC, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, Karim R, Putti TC.

Hum Pathol. 2004 Sep;35(9):1053-7.

PMID:
15343505
11.

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

Yonemori K, Hasegawa T, Shimizu C, Shibata T, Matsumoto K, Kouno T, Ando M, Katsumata N, Fujiwara Y.

Pathol Res Pract. 2006;202(10):705-12. Epub 2006 Aug 2.

PMID:
16889904
12.

p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.

Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, Bay BH.

Mod Pathol. 2005 Dec;18(12):1527-34.

13.

Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior.

Burga AM, Tavassoli FA.

Am J Surg Pathol. 2003 Mar;27(3):343-8.

PMID:
12604890
14.

Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.

Tse GM, Putti TC, Lui PC, Lo AW, Scolyer RA, Law BK, Karim R, Lee CS.

Mod Pathol. 2004 Jul;17(7):827-31.

15.

Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases.

Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, Putti TC.

Am J Clin Pathol. 2002 Oct;118(4):522-6.

PMID:
12375638
16.

Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.

Ang MK, Ooi AS, Thike AA, Tan P, Zhang Z, Dykema K, Furge K, Teh BT, Tan PH.

Breast Cancer Res Treat. 2011 Sep;129(2):319-29. doi: 10.1007/s10549-010-1204-5. Epub 2010 Oct 14.

PMID:
20945089
17.

Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.

Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, Liu TP.

J Surg Oncol. 2005 Sep 1;91(3):185-94.

PMID:
16118768
18.

Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.

Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, Dei Tos AP, Fortunati N, Catalano MG, Bussolati G.

Mod Pathol. 2006 Apr;19(4):599-606.

19.

[Phyllodes tumor of the breast: clinicopathologic analysis of 22 cases].

Velázquez-Dohorn M, Gamboa-Domínguez A, Medina-Franco H.

Rev Invest Clin. 2013 May-Jun;65(3):214-20. Spanish.

PMID:
23877808
20.

Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.

Tse GM, Lui PC, Vong JS, Lau KM, Putti TC, Karim R, Scolyer RA, Lee CS, Yu AM, Ng DC, Tse AK, Tan PH.

Breast Cancer Res Treat. 2009 Apr;114(3):441-8. doi: 10.1007/s10549-008-0030-5. Epub 2008 Apr 29.

PMID:
18443904

Supplemental Content

Support Center